No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 6g57A, 0.5718, 3.05, 0.790, 97, 81, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD8 
2, 6qzlB, 0.5705, 3.05, 0.525, 98, 80, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
3, 6qzlD, 0.5698, 2.95, 0.557, 96, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
4, 6qzlA, 0.5681, 3.09, 0.556, 103, 81, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
5, 6qzlE, 0.5643, 3.03, 0.575, 93, 80, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
6, 6qzlC, 0.5635, 3.16, 0.556, 100, 81, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD12 
7, 6g57B, 0.5627, 3.10, 0.797, 93, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD8 
8, 6m8sB, 0.5624, 3.02, 0.570, 101, 79, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
9, 6m8sP, 0.5614, 3.03, 0.538, 104, 78, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
10, 6m8sA, 0.5608, 2.98, 0.538, 104, 78, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
11, 6m8sM, 0.5590, 3.05, 0.570, 106, 79, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
12, 6m8sO, 0.5570, 2.93, 0.590, 105, 78, CRYSTAL STRUCTURE OF THE KCTD12 H1 DOMAIN IN COMPLEX WITH GBETA1GAMMA2 SUBUNITS 
13, 6qb7B, 0.5558, 2.97, 0.582, 114, 79, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
14, 6qb7D, 0.5552, 3.07, 0.562, 112, 80, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
15, 6qb7C, 0.5547, 3.09, 0.562, 112, 80, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
16, 6qb7A, 0.5541, 3.10, 0.562, 114, 80, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
17, 6qb7E, 0.5540, 3.18, 0.580, 113, 81, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD16 
18, 6g57C, 0.5478, 2.77, 0.787, 88, 75, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD8 
19, 2o8bA, 0.5348, 3.91, 0.145, 831, 83, HUMAN MUTSALPHA (MSH2/MSH6) BOUND TO ADP AND A G T MISPAIR
20, 2o8cA, 0.5343, 3.90, 0.145, 830, 83, HUMAN MUTSALPHA (MSH2/MSH6) BOUND TO ADP AND AN O6-METHYL-GUANINE T MISPAIR
21, 2o8dA, 0.5340, 3.92, 0.145, 830, 83, HUMAN MUTSALPHA (MSH2/MSH6) BOUND TO ADP AND A G DU MISPAIR
22, 2o8fA, 0.5330, 3.92, 0.145, 832, 83, HUMAN MUTSALPHA (MSH2/MSH6) BOUND TO DNA WITH A SINGLE BASE T INSERT
23, 5espA, 0.5320, 3.95, 0.037, 292, 81, CRYSTAL STRUCTURE OF LAGLIDADG MEGANUCLEASE I-PANMI WITH COORDINATED CALCIUM IONS
24, 2o8eA, 0.5306, 3.88, 0.159, 824, 82, HUMAN MUTSALPHA (MSH2/MSH6) BOUND TO A G T MISPAIR WITH ADP BOUND TO MSH2 ONLY
25, 6g57D, 0.5294, 2.66, 0.611, 82, 72, STRUCTURE OF THE H1 DOMAIN OF HUMAN KCTD8 
26, 4yisA, 0.5290, 3.98, 0.036, 295, 84, CRYSTAL STRUCTURE OF LAGLIDADG MEGANUCLEASE I-CPAMI BOUND TO UNCLEAVED DNA
27, 5t8dA, 0.5286, 3.95, 0.111, 292, 81, ENGINEERED VARIANT OF I-ONUI MEGANUCLEASE TARGETING THE HIV INTEGRASE GENE; HARBORS 47 POINT MUTATIONS RELATIVE TO WILD-TYPE I-ONUI
28, 5thgA, 0.5269, 3.94, 0.123, 294, 81, ENGINEERED VARIANT OF I-ONUI MEGANUCLEASE TARGETING THE HIV CCR5 GENE; HARBORS 43 POINT MUTATIONS RELATIVE TO WILD-TYPE I-ONUI
29, 6bcgG, 0.5262, 3.94, 0.025, 281, 80, I-LTRI A28G BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
30, 5v0qA, 0.5261, 3.97, 0.111, 291, 81, ORIGINAL ENGINEERED VARIANT OF I-ONUI MEGANUCLEASE TARGETING THE HIV INTEGRASE GENE; HARBORS 49 POINT MUTATIONS RELATIVE TO WILD-TYPE I- ONUI
31, 5e67A, 0.5259, 3.95, 0.099, 294, 81, K103A/K262A DOUBLE MUTANT OF I-SMAMI
32, 4z1xB, 0.5259, 4.07, 0.122, 291, 82, CRYSTAL STRUCTURE OF LAGLIDADG HOMING ENDONUCLEASE I-GZEII IN COMPLEX WITH DNA TARGET
33, 3thyA, 0.5258, 3.62, 0.152, 883, 79, HUMAN MUTSBETA COMPLEXED WITH AN IDL OF 2 BASES (LOOP2) AND ADP
34, 6bcgJ, 0.5251, 3.98, 0.025, 282, 80, I-LTRI A28G BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
35, 3thxA, 0.5250, 3.62, 0.152, 868, 79, HUMAN MUTSBETA COMPLEXED WITH AN IDL OF 3 BASES (LOOP3) AND ADP
36, 5thgD, 0.5246, 3.96, 0.123, 291, 81, ENGINEERED VARIANT OF I-ONUI MEGANUCLEASE TARGETING THE HIV CCR5 GENE; HARBORS 43 POINT MUTATIONS RELATIVE TO WILD-TYPE I-ONUI
37, 5e63A, 0.5245, 3.83, 0.100, 293, 80, K262A MUTANT OF I-SMAMI
38, 4efjB, 0.5242, 4.09, 0.122, 291, 82, CRYSTAL STRUCTURE OF I-GZEII LAGLIDADG HOMING ENDONUCLEASE IN COMPLEX WITH DNA TARGET SITE
39, 4loxA, 0.5238, 4.11, 0.120, 300, 83, CRYSTAL STRUCTURE OF THE I-SMAMI LAGLIDADG HOMING ENDONUCLEASE BOUND TO CLEAVED DNA
40, 4yitD, 0.5236, 3.79, 0.063, 277, 79, CRYSTAL STRUCTURE OF LAGLIDADG MEGANUCLEASE I-AABMI BOUND TO UNCLEAVED DNA
41, 3r7pA, 0.5236, 3.99, 0.037, 292, 80, THE CRYSTAL STRUCTURE OF I-LTRI
42, 3thzA, 0.5235, 3.68, 0.137, 888, 80, HUMAN MUTSBETA COMPLEXED WITH AN IDL OF 6 BASES (LOOP6) AND ADP
43, 4z20D, 0.5233, 3.90, 0.050, 291, 80, CRYSTAL STRUCTURE OF MEGANUCLEASE I-SMAMI BOUND TO UNCLEAVEABLE DNA WITH A TTGT CENTRAL FOUR
44, 1is8N, 0.5229, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
45, 1is8L, 0.5229, 3.29, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
46, 1is8S, 0.5228, 3.29, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
47, 1is8R, 0.5228, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
48, 1is8P, 0.5228, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
49, 1is8M, 0.5228, 3.29, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
50, 1is8Q, 0.5227, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
51, 1is8O, 0.5227, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
52, 1is8K, 0.5226, 3.29, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
53, 1is8T, 0.5225, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN
54, 4z1zB, 0.5224, 3.84, 0.100, 295, 80, CRYSTAL STRUCTURE OF MEGANUCLEASE I-SMAMI BOUND TO UNCLEAVEABLE DNA WITH A TTCT CENTRAL FOUR
55, 1is7N, 0.5222, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
56, 1is7P, 0.5220, 3.31, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
57, 1is7L, 0.5219, 3.31, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
58, 6bcgD, 0.5218, 3.95, 0.025, 287, 80, I-LTRI A28G BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
59, 1is7R, 0.5218, 3.31, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
60, 1is7Q, 0.5218, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
61, 1is7O, 0.5218, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
62, 1is7M, 0.5218, 3.30, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
63, 5e5sA, 0.5217, 3.86, 0.100, 297, 80, I-SMAMI K103A MUTANT
64, 1is7S, 0.5217, 3.31, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
65, 1is7K, 0.5215, 3.31, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
66, 1is7T, 0.5214, 3.31, 0.105, 84, 76, CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX
67, 4yhxA, 0.5212, 3.78, 0.100, 294, 80, CRYSTAL STRUCTURE OF LAGLIDADG MEGANUCLEASE I-GPEMI BOUND TO UNCLEAVED DNA
68, 6bcnC, 0.5210, 3.97, 0.037, 290, 80, I-LTRI E184D BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
69, 6bceA, 0.5207, 3.93, 0.037, 289, 80, WILD-TYPE I-LTRI BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
70, 6bcfG, 0.5198, 3.86, 0.038, 288, 79, I-LTRI G183A BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
71, 1wplQ, 0.5198, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
72, 6bcnA, 0.5197, 3.97, 0.037, 291, 80, I-LTRI E184D BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
73, 1wplK, 0.5197, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
74, 6bchL, 0.5196, 3.96, 0.025, 289, 80, I-LTRI E29D BOUND TO COGNATE SUBSTRATE (NICKED COMPLEX) 
75, 1wplM, 0.5196, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
76, 1wplO, 0.5195, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
77, 6bchD, 0.5193, 4.03, 0.025, 289, 81, I-LTRI E29D BOUND TO COGNATE SUBSTRATE (NICKED COMPLEX) 
78, 3thwA, 0.5193, 3.72, 0.125, 890, 80, HUMAN MUTSBETA COMPLEXED WITH AN IDL OF 4 BASES (LOOP4) AND ADP
79, 1wplT, 0.5193, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
80, 1wplS, 0.5193, 3.32, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
81, 6bchA, 0.5192, 3.96, 0.025, 289, 80, I-LTRI E29D BOUND TO COGNATE SUBSTRATE (NICKED COMPLEX) 
82, 1wplR, 0.5192, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
83, 1wplP, 0.5192, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
84, 6bchH, 0.5191, 4.03, 0.025, 289, 81, I-LTRI E29D BOUND TO COGNATE SUBSTRATE (NICKED COMPLEX) 
85, 1jg5C, 0.5191, 3.27, 0.122, 83, 74, CRYSTAL STRUCTURE OF RAT GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN GFRP
86, 6bcgA, 0.5190, 3.91, 0.025, 282, 80, I-LTRI A28G BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
87, 5t2nA, 0.5190, 4.04, 0.111, 291, 81, ENGINEERED VARIANT OF I-ONUI MEGANUCLEASE TARGETING THE ANOPHELES AGAP007280 GENE; HARBORS 38 POINT MUTATIONS RELATIVE TO WILD-TYPE I- ONUI
88, 1wplN, 0.5190, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
89, 1wplL, 0.5190, 3.31, 0.120, 84, 75, CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX
90, 1jg5A, 0.5190, 3.31, 0.107, 83, 75, CRYSTAL STRUCTURE OF RAT GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN GFRP
91, 6bcfD, 0.5189, 4.07, 0.037, 288, 81, I-LTRI G183A BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
92, 4z1zA, 0.5188, 3.89, 0.099, 294, 81, CRYSTAL STRUCTURE OF MEGANUCLEASE I-SMAMI BOUND TO UNCLEAVEABLE DNA WITH A TTCT CENTRAL FOUR
93, 1jg5E, 0.5187, 3.20, 0.122, 83, 74, CRYSTAL STRUCTURE OF RAT GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN GFRP
94, 5t2oA, 0.5181, 3.95, 0.112, 293, 80, ENGINEERED VARIANT OF I-ONUI MEGANUCLEASE TARGETING THE ANOPHELES AGAP011377 GENE; HARBORS 53 POINT MUTATIONS RELATIVE TO WILD-TYPE I- ONUI
95, 6bcnJ, 0.5180, 4.03, 0.037, 290, 81, I-LTRI E184D BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
96, 6bciA, 0.5180, 3.81, 0.025, 292, 79, WILD-TYPE I-LTRI BOUND TO NON-COGNATE C4 SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
97, 4yitA, 0.5178, 3.85, 0.064, 272, 78, CRYSTAL STRUCTURE OF LAGLIDADG MEGANUCLEASE I-AABMI BOUND TO UNCLEAVED DNA
98, 1jg5B, 0.5177, 3.28, 0.122, 83, 74, CRYSTAL STRUCTURE OF RAT GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN GFRP
99, 1jg5D, 0.5176, 3.29, 0.122, 83, 74, CRYSTAL STRUCTURE OF RAT GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN GFRP
100, 6bcfA, 0.5172, 3.87, 0.038, 288, 79, I-LTRI G183A BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
101, 6bcnG, 0.5171, 3.99, 0.037, 290, 80, I-LTRI E184D BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
102, 1w16A, 0.5157, 3.64, 0.105, 125, 76, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE ABSENCE OF CALCIUM
103, 1i7sA, 0.5156, 3.71, 0.065, 511, 77, ANTHRANILATE SYNTHASE FROM SERRATIA MARCESCENS IN COMPLEX WITH ITS END PRODUCT INHIBITOR L-TRYPTOPHAN
104, 6bcfJ, 0.5151, 4.00, 0.037, 289, 81, I-LTRI G183A BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
105, 6bctA, 0.5144, 3.83, 0.025, 290, 79, I-LTRI E184D BOUND TO NON-COGNATE C4 SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
106, 4efjA, 0.5142, 3.97, 0.072, 291, 83, CRYSTAL STRUCTURE OF I-GZEII LAGLIDADG HOMING ENDONUCLEASE IN COMPLEX WITH DNA TARGET SITE
107, 4lq0A, 0.5140, 3.92, 0.037, 298, 80, CRYSTAL STRUCTURE OF THE I-LTRWI LAGLIDADG HOMING ENDONUCLEASE BOUND TO TARGET DNA.
108, 5gkkA, 0.5133, 4.05, 0.098, 147, 82, CRYSTAL STRUCTURE OF A HOMING ENDONUCLEASE I-TNAI
109, 1i7sC, 0.5129, 3.64, 0.052, 511, 77, ANTHRANILATE SYNTHASE FROM SERRATIA MARCESCENS IN COMPLEX WITH ITS END PRODUCT INHIBITOR L-TRYPTOPHAN
110, 3mxaA, 0.5124, 3.97, 0.075, 301, 80, MOLECULAR BASIS OF ENGINEERED MEGANUCLEASE TARGETING OF THE ENDOGENOUS HUMAN RAG1 LOCUS
111, 5gkkB, 0.5121, 4.10, 0.099, 144, 81, CRYSTAL STRUCTURE OF A HOMING ENDONUCLEASE I-TNAI
112, 1w15A, 0.5120, 3.57, 0.107, 132, 75, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE PRESENCE OF CALCIUM
113, 2ex5A, 0.5118, 4.02, 0.111, 207, 81, GROUP I INTRON-ENCODED HOMING ENDONUCLEASE I-CEUI COMPLEXED WITH DNA
114, 3mx9A, 0.5113, 4.05, 0.062, 298, 81, MOLECULAR BASIS OF ENGINEERED MEGANUCLEASE TARGETING OF THE ENDOGENOUS HUMAN RAG1 LOCUS
115, 2ex5B, 0.5110, 3.89, 0.099, 207, 81, GROUP I INTRON-ENCODED HOMING ENDONUCLEASE I-CEUI COMPLEXED WITH DNA
116, 1mowA, 0.5109, 4.04, 0.062, 248, 81, E-DREI
117, 1mowD, 0.5106, 4.04, 0.062, 248, 81, E-DREI
118, 5t2hA, 0.5099, 4.05, 0.061, 296, 82, ENGINEERED VARIANT OF I-ONUI MEGANUCLEASE TARGETING THE HUMAN TCRA GENE; HARBORS 43 POINT MUTATIONS RELATIVE TO WILD-TYPE I-ONUI
119, 4z1xA, 0.5098, 3.84, 0.072, 291, 83, CRYSTAL STRUCTURE OF LAGLIDADG HOMING ENDONUCLEASE I-GZEII IN COMPLEX WITH DNA TARGET
120, 2qqpE, 0.5095, 3.78, 0.062, 517, 80, CRYSTAL STRUCTURE OF AUTHENTIC PROVIDENCE VIRUS
121, 1mowG, 0.5087, 3.71, 0.090, 233, 78, E-DREI
122, 5espB, 0.5076, 4.12, 0.061, 288, 82, CRYSTAL STRUCTURE OF LAGLIDADG MEGANUCLEASE I-PANMI WITH COORDINATED CALCIUM IONS
123, 2qqpA, 0.5075, 4.03, 0.049, 484, 82, CRYSTAL STRUCTURE OF AUTHENTIC PROVIDENCE VIRUS
124, 3fd2A, 0.5071, 3.91, 0.086, 338, 81, CRYSTAL STRUCTURE OF MMSOI/DNA COMPLEX WITH CALCIUM
125, 1i7qA, 0.5071, 4.00, 0.090, 517, 78, ANTHRANILATE SYNTHASE FROM S. MARCESCENS
126, 3n5aA, 0.5068, 3.94, 0.130, 138, 77, SYNAPTOTAGMIN-7 C2B-DOMAIN CALCIUM BOUND
127, 6bdbA, 0.5067, 4.21, 0.084, 295, 83, I-ONUI K227Y; D236A BOUND TO A3G SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
128, 6bd0A, 0.5061, 4.10, 0.085, 300, 82, I-ONUI K227Y; D236A BOUND TO COGNATE SUBSTRATE (PRE-CLEAVAGE COMPLEX) 
129, 4yisB, 0.5060, 4.18, 0.061, 284, 82, CRYSTAL STRUCTURE OF LAGLIDADG MEGANUCLEASE I-CPAMI BOUND TO UNCLEAVED DNA
130, 4mexI, 0.5057, 3.89, 0.062, 1340, 80, CRYSTAL STRUCTURE OF ESCHERICHIA COLI RNA POLYMERASE IN COMPLEX WITH SALINAMIDE A
131, 3hn8B, 0.5049, 3.66, 0.067, 279, 75, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
132, 3hn8A, 0.5049, 3.66, 0.067, 279, 75, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
133, 3e54B, 0.5049, 4.12, 0.123, 159, 81, ARCHAEAL INTRON-ENCODED HOMING ENDONUCLEASE I-VDI141I COMPLEXED WITH DNA
134, 3hn8C, 0.5048, 4.12, 0.076, 279, 79, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
135, 4ylnO, 0.5047, 3.83, 0.063, 1341, 79, E. COLI TRANSCRIPTION INITIATION COMPLEX - 17-BP SPACER AND 4-NT RNA
136, 3e54A, 0.5043, 4.11, 0.123, 159, 81, ARCHAEAL INTRON-ENCODED HOMING ENDONUCLEASE I-VDI141I COMPLEXED WITH DNA
137, 2qqpC, 0.5042, 3.90, 0.062, 484, 80, CRYSTAL STRUCTURE OF AUTHENTIC PROVIDENCE VIRUS
138, 1i1qA, 0.5040, 3.93, 0.078, 512, 77, STRUCTURE OF THE COOPERATIVE ALLOSTERIC ANTHRANILATE SYNTHASE FROM SALMONELLA TYPHIMURIUM
139, 6awbD, 0.5039, 4.42, 0.059, 1327, 85, struct.pdbx_descriptor              
140, 1n61C, 0.5036, 3.83, 0.062, 287, 80, CRYSTAL STRUCTURE OF THE CUMO-CO DEHYDROGENASE (CODH); DITHIONITE REDUCED STATE
141, 1i7qC, 0.5033, 4.07, 0.089, 517, 79, ANTHRANILATE SYNTHASE FROM S. MARCESCENS
142, 1n62F, 0.5031, 3.81, 0.061, 286, 82, CRYSTAL STRUCTURE OF THE MOCU-CO DEHYDROGENASE (CODH) N- BUTYLISOCYANIDE-BOUND STATE
143, 3uvfA, 0.5030, 3.74, 0.039, 255, 77, EXPANDING LAGALIDADG ENDONUCLEASE SCAFFOLD DIVERSITY BY RAPIDLY SURVEYING EVOLUTIONARY SEQUENCE SPACE
144, 4mexC, 0.5029, 3.77, 0.063, 1340, 79, CRYSTAL STRUCTURE OF ESCHERICHIA COLI RNA POLYMERASE IN COMPLEX WITH SALINAMIDE A
145, 6bdaA, 0.5028, 4.12, 0.084, 295, 83, WILD-TYPE I-ONUI BOUND TO A3G SUBSTRATE (POST-CLEAVAGE COMPLEX) 
146, 5e5oA, 0.5023, 4.24, 0.059, 294, 85, I-SMAMI BOUND TO UNCLEAVED DNA TARGET IN THE PRESENCE OF CALCIUM IONS
147, 3hrdG, 0.5022, 3.88, 0.062, 292, 81, CRYSTAL STRUCTURE OF NICOTINATE DEHYDROGENASE
148, 1mowJ, 0.5018, 3.79, 0.090, 234, 78, E-DREI
149, 5e5pA, 0.5017, 4.16, 0.082, 295, 85, WILD TYPE I-SMAMI IN THE SPACE GROUP OF C121
150, 1n62C, 0.5016, 3.96, 0.060, 286, 83, CRYSTAL STRUCTURE OF THE MOCU-CO DEHYDROGENASE (CODH) N- BUTYLISOCYANIDE-BOUND STATE
151, 3qqyA, 0.5015, 4.04, 0.073, 299, 82, CRYSTAL STRUCTURE OF A NOVEL LAGLIDADG HOMING ENDONUCLEASE I-ONUI (FROM OPHIOSTOMA NOVO-ULMI SUBSP. AMERICANA)
152, 3uvfB, 0.5012, 3.74, 0.039, 255, 77, EXPANDING LAGALIDADG ENDONUCLEASE SCAFFOLD DIVERSITY BY RAPIDLY SURVEYING EVOLUTIONARY SEQUENCE SPACE
153, 4z20A, 0.5009, 3.98, 0.073, 298, 82, CRYSTAL STRUCTURE OF MEGANUCLEASE I-SMAMI BOUND TO UNCLEAVEABLE DNA WITH A TTGT CENTRAL FOUR
154, 5ms0C, 0.5008, 4.07, 0.062, 1291, 81, PSEUDO-ATOMIC MODEL OF THE RNA POLYMERASE LAMBDA-BASED ANTITERMINATION COMPLEX SOLVED BY CRYO-EM
155, 2g0jC, 0.5008, 3.06, 0.082, 116, 73, CRYSTAL STRUCTURE OF SMU.848 FROM STREPTOCOCCUS MUTANS
156, 5a72B, 0.5003, 4.07, 0.112, 158, 80, CRYSTAL STRUCTURE OF THE HOMING ENDONUCLEASE I-CVUI IN COMPLEX WITH ITS TARGET (SRO1.3) IN THE PRESENCE OF 2 MM CA
